Literature DB >> 22951414

Heterotypic three-dimensional in vitro modeling of stromal-epithelial interactions during ovarian cancer initiation and progression.

Kate Lawrenson1, Barbara Grun, Simon A Gayther.   

Abstract

Epithelial ovarian cancers (EOCs) are the leading cause of death from gynecological malignancy in Western societies. Despite advances in surgical treatments and improved platinum-based chemotherapies, there has been little improvement in EOC survival rates for more than four decades. Whilst stage I tumors have 5-year survival rates >85%, survival rates for stage III/IV disease are <40%. Thus, the high rates of mortality for EOC could be significantly decreased if tumors were detected at earlier, more treatable, stages. At present, the molecular genetic and biological basis of early stage disease development is poorly understood. More specifically, little is known about the role of the microenvironment during tumor initiation; but known risk factors for EOCs (e.g. age and parity) suggest that the microenvironment plays a key role in the early genesis of EOCs. We therefore developed three-dimensional heterotypic models of both the normal ovary and of early stage ovarian cancers. For the normal ovary, we co-cultured normal ovarian surface epithelial (IOSE) and normal stromal fibroblast (INOF) cells, immortalized by retrovrial transduction of the catalytic subunit of human telomerase holoenzyme (hTERT) to extend the lifespan of these cells in culture. To model the earliest stages of ovarian epithelial cell transformation, overexpression of the CMYC oncogene in IOSE cells, again co-cultured with INOF cells. These heterotypic models were used to investigate the effects of aging and senescence on the transformation and invasion of epithelial cells. Here we describe the methodological steps in development of these three-dimensional model; these methodologies aren't specific to the development of normal ovary and ovarian cancer tissues, and could be used to study other tissue types where stromal and epithelial cell interactions are a fundamental aspect of the tissue maintenance and disease development.

Entities:  

Mesh:

Year:  2012        PMID: 22951414      PMCID: PMC3486769          DOI: 10.3791/4206

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  15 in total

1.  In vitro three-dimensional modelling of human ovarian surface epithelial cells.

Authors:  K Lawrenson; E Benjamin; M Turmaine; I Jacobs; S Gayther; D Dafou
Journal:  Cell Prolif       Date:  2009-04-24       Impact factor: 6.831

2.  Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP).

Authors:  N W Kim; F Wu
Journal:  Nucleic Acids Res       Date:  1997-07-01       Impact factor: 16.971

3.  Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer.

Authors:  Kate Lawrenson; Barbara Grun; Elizabeth Benjamin; Ian J Jacobs; Dimitra Dafou; Simon A Gayther
Journal:  Neoplasia       Date:  2010-04       Impact factor: 5.715

Review 4.  New insights into the pathogenesis of serous ovarian cancer and its clinical impact.

Authors:  Keren Levanon; Christopher Crum; Ronny Drapkin
Journal:  J Clin Oncol       Date:  2008-10-14       Impact factor: 44.544

5.  Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC).

Authors:  Magdalena Zietarska; Christine M Maugard; Abdelali Filali-Mouhim; Mona Alam-Fahmy; Patricia N Tonin; Diane M Provencher; Anne-Marie Mes-Masson
Journal:  Mol Carcinog       Date:  2007-10       Impact factor: 4.784

6.  Three-dimensional in vitro cell biology models of ovarian and endometrial cancer.

Authors:  B Grun; E Benjamin; J Sinclair; J F Timms; I J Jacobs; S A Gayther; D Dafou
Journal:  Cell Prolif       Date:  2009-02-16       Impact factor: 6.831

Review 7.  Multicellular spheroids in ovarian cancer metastases: Biology and pathology.

Authors:  Kristy Shield; M Leigh Ackland; Nuzhat Ahmed; Gregory E Rice
Journal:  Gynecol Oncol       Date:  2009-01-10       Impact factor: 5.482

8.  Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implications.

Authors:  Martin Köbel; Steve E Kalloger; Jennifer L Santos; David G Huntsman; C Blake Gilks; Kenneth D Swenerton
Journal:  Gynecol Oncol       Date:  2009-10-12       Impact factor: 5.482

9.  Impartial comparative analysis of measurement of leukocyte telomere length/DNA content by Southern blots and qPCR.

Authors:  Abraham Aviv; Steven C Hunt; Jue Lin; Xiaojian Cao; Masayuki Kimura; Elizabeth Blackburn
Journal:  Nucleic Acids Res       Date:  2011-08-08       Impact factor: 16.971

10.  Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.

Authors:  Martin Köbel; Steve E Kalloger; Niki Boyd; Steven McKinney; Erika Mehl; Chana Palmer; Samuel Leung; Nathan J Bowen; Diana N Ionescu; Ashish Rajput; Leah M Prentice; Dianne Miller; Jennifer Santos; Kenneth Swenerton; C Blake Gilks; David Huntsman
Journal:  PLoS Med       Date:  2008-12-02       Impact factor: 11.069

View more
  8 in total

Review 1.  Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk.

Authors:  Siddhartha P Kar; Jonathan P Tyrer; Qiyuan Li; Kate Lawrenson; Katja K H Aben; Hoda Anton-Culver; Natalia Antonenkova; Georgia Chenevix-Trench; Helen Baker; Elisa V Bandera; Yukie T Bean; Matthias W Beckmann; Andrew Berchuck; Maria Bisogna; Line Bjørge; Natalia Bogdanova; Louise Brinton; Angela Brooks-Wilson; Ralf Butzow; Ian Campbell; Karen Carty; Jenny Chang-Claude; Yian Ann Chen; Zhihua Chen; Linda S Cook; Daniel Cramer; Julie M Cunningham; Cezary Cybulski; Agnieszka Dansonka-Mieszkowska; Joe Dennis; Ed Dicks; Jennifer A Doherty; Thilo Dörk; Andreas du Bois; Matthias Dürst; Diana Eccles; Douglas F Easton; Robert P Edwards; Arif B Ekici; Peter A Fasching; Brooke L Fridley; Yu-Tang Gao; Aleksandra Gentry-Maharaj; Graham G Giles; Rosalind Glasspool; Ellen L Goode; Marc T Goodman; Jacek Grownwald; Patricia Harrington; Philipp Harter; Alexander Hein; Florian Heitz; Michelle A T Hildebrandt; Peter Hillemanns; Estrid Hogdall; Claus K Hogdall; Satoyo Hosono; Edwin S Iversen; Anna Jakubowska; James Paul; Allan Jensen; Bu-Tian Ji; Beth Y Karlan; Susanne K Kjaer; Linda E Kelemen; Melissa Kellar; Joseph Kelley; Lambertus A Kiemeney; Camilla Krakstad; Jolanta Kupryjanczyk; Diether Lambrechts; Sandrina Lambrechts; Nhu D Le; Alice W Lee; Shashi Lele; Arto Leminen; Jenny Lester; Douglas A Levine; Dong Liang; Jolanta Lissowska; Karen Lu; Jan Lubinski; Lene Lundvall; Leon Massuger; Keitaro Matsuo; Valerie McGuire; John R McLaughlin; Iain A McNeish; Usha Menon; Francesmary Modugno; Kirsten B Moysich; Steven A Narod; Lotte Nedergaard; Roberta B Ness; Heli Nevanlinna; Kunle Odunsi; Sara H Olson; Irene Orlow; Sandra Orsulic; Rachel Palmieri Weber; Celeste Leigh Pearce; Tanja Pejovic; Liisa M Pelttari; Jennifer Permuth-Wey; Catherine M Phelan; Malcolm C Pike; Elizabeth M Poole; Susan J Ramus; Harvey A Risch; Barry Rosen; Mary Anne Rossing; Joseph H Rothstein; Anja Rudolph; Ingo B Runnebaum; Iwona K Rzepecka; Helga B Salvesen; Joellen M Schildkraut; Ira Schwaab; Xiao-Ou Shu; Yurii B Shvetsov; Nadeem Siddiqui; Weiva Sieh; Honglin Song; Melissa C Southey; Lara E Sucheston-Campbell; Ingvild L Tangen; Soo-Hwang Teo; Kathryn L Terry; Pamela J Thompson; Agnieszka Timorek; Ya-Yu Tsai; Shelley S Tworoger; Anne M van Altena; Els Van Nieuwenhuysen; Ignace Vergote; Robert A Vierkant; Shan Wang-Gohrke; Christine Walsh; Nicolas Wentzensen; Alice S Whittemore; Kristine G Wicklund; Lynne R Wilkens; Yin-Ling Woo; Xifeng Wu; Anna Wu; Hannah Yang; Wei Zheng; Argyrios Ziogas; Thomas A Sellers; Alvaro N A Monteiro; Matthew L Freedman; Simon A Gayther; Paul D P Pharoah
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-07-24       Impact factor: 4.254

2.  Tumor microenvironment-associated modifications of alternative splicing.

Authors:  Jean-Philippe Brosseau; Jean-François Lucier; Hanad Nwilati; Philippe Thibault; Daniel Garneau; Daniel Gendron; Mathieu Durand; Sonia Couture; Elvy Lapointe; Panagiotis Prinos; Roscoe Klinck; Jean-Pierre Perreault; Benoit Chabot; Sherif Abou-Elela
Journal:  RNA       Date:  2013-12-11       Impact factor: 4.942

3.  Early transcriptional response of human ovarian and fallopian tube surface epithelial cells to norepinephrine.

Authors:  Anxhela Gjyshi; Sweta Dash; Ling Cen; Chia-Ho Cheng; Chaomei Zhang; Sean J Yoder; Jamie K Teer; Guillermo N Armaiz-Pena; Alvaro N A Monteiro
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

4.  Reduced Basal Nitric Oxide Production Induces Precancerous Mammary Lesions via ERBB2 and TGFβ.

Authors:  Gang Ren; Xunzhen Zheng; Matthew Bommarito; Samantha Metzger; Yashna Walia; Joshua Letson; Allen Schroering; Andrea Kalinoski; David Weaver; Christopher Figy; Kam Yeung; Saori Furuta
Journal:  Sci Rep       Date:  2019-04-30       Impact factor: 4.379

Review 5.  Using Spheroids as Building Blocks Towards 3D Bioprinting of Tumor Microenvironment.

Authors:  Pei Zhuang; Yi-Hua Chiang; Maria Serafim Fernanda; Mei He
Journal:  Int J Bioprint       Date:  2021-10-21

Review 6.  Three-Dimensional Modelling of Ovarian Cancer: From Cell Lines to Organoids for Discovery and Personalized Medicine.

Authors:  Christine Yee; Kristie-Ann Dickson; Mohammed N Muntasir; Yue Ma; Deborah J Marsh
Journal:  Front Bioeng Biotechnol       Date:  2022-02-10

Review 7.  Culture models to define key mediators of cancer matrix remodeling.

Authors:  Emily Suzanne Fuller; Viive Maarika Howell
Journal:  Front Oncol       Date:  2014-03-25       Impact factor: 6.244

8.  Targeting Oxidative Phosphorylation-Proteasome Activity in Extracellular Detached Cells Promotes Anoikis and Inhibits Metastasis.

Authors:  Funmilayo O Adeshakin; Adeleye O Adeshakin; Zhao Liu; Jian Cheng; Pengchao Zhang; Dehong Yan; Guizhong Zhang; Xiaochun Wan
Journal:  Life (Basel)       Date:  2021-12-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.